Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00410501
Status:
COMPLETED
Last Update Posted:
2007-06-19
First Post:
2006-12-12
Brief Title:
Evaluation of Pharmacokinetic Interaction of Indacaterol With Ketoconazole in Healthy Adult Subjects
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
An Open Label Single Dose Two Period Single Sequence Crossover Study to Assess the Pharmacokinetic Interaction of QAB149 300 Mcg Via Inhalation With Ketoconazole 200 mg Tablet bid in Healthy Adult Subjects
Status:
COMPLETED
Status Verified Date:
2007-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will evaluate the interaction potential between indacaterol and ketoconazole a potent CYP3A inhibitor in healthy adult subjects
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None